A more recent review describes this as a bidirectional relationship: GLP-1 drugs can shift the microbiome, and a person's existing microbiome may also predict how well they respond to the medication ( Frontiers in Endocrinology , 2026)
In summary, alterations at the glutathione activator site result in an absent geometric and electrostatic complementary 3,50 for the reducing agent, explaining the inefficient reduction of numerous glutaredoxins 12,25,26,27,28,29,48 and thioredoxins by GSH
In the context of risk of confounding by indication, propensity score matching was not expected to provide additional reduction of residual confounding beyond the applied covariate adjustment (psychiatric, somatic, and sociodemographic factors) and self-controlled analyses [33]
When you inject a medication into your body (or take a pill), you deserve to know it was tested, verified and produced under strict quality standards